Vulnerability Monitor

The vendors, products, and vulnerabilities you care about

CVE-2017-14111

The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an attacker to use credentials to access the application, or other user entitlements.

Security Impact Summary

This vulnerability carries a HIGH severity rating with a CVSS v3.1 score of 7.2, indicating it can be exploited remotely over the network with relatively low complexity without requiring user interaction . The vulnerability impacts confidentiality (data exposure), integrity (unauthorized modifications), and availability (service disruption) for affected systems. Impacting 2 products from philips, from philips organizations running these solutions should prioritize assessment and patching.

Historical Context

First disclosed in 2017, this vulnerability was reported during a period defined by widespread IoT adoption challenges, mobile security concerns, and the emergence of advanced persistent threat (APT) techniques. Contemporary mitigation strategies focused on secure development practices and third-party component vetting.

Published

2017-11-17T20:29:00.323

Last Modified

2025-04-20T01:37:25.860

Status

Deferred

Source

[email protected]

Severity

CVSSv3.0: 7.2 (HIGH)

CVSSv2 Vector

AV:N/AC:L/Au:S/C:P/I:N/A:N

Access Vector: NETWORK
Access Complexity: LOW
Authentication: SINGLE
Confidentiality Impact: PARTIAL
Integrity Impact: NONE
Availability Impact: NONE

Exploitability Score

8.0

Impact Score

2.9

Weaknesses

Type: Primary
CWE-522

Affected Vendors & Products

Type	Vendor	Product	Version/Range	Vulnerable?
Application	philips	intellispace_cardiovascular	≤ 2.3.0	Yes
Application	philips	xcelera	≤ r4.1l1	Yes

References

http://www.securityfocus.com/bid/101850 Third Party Advisory, VDB Entry ([email protected])
https://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01 Issue Tracking, Third Party Advisory, US Government Resource ([email protected])
https://www.usa.philips.com/healthcare/about/customer-support/product-security Issue Tracking, Mitigation, Vendor Advisory ([email protected])
http://www.securityfocus.com/bid/101850 Third Party Advisory, VDB Entry (af854a3a-2127-422b-91ae-364da2661108)
https://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01 Issue Tracking, Third Party Advisory, US Government Resource (af854a3a-2127-422b-91ae-364da2661108)
https://www.usa.philips.com/healthcare/about/customer-support/product-security Issue Tracking, Mitigation, Vendor Advisory (af854a3a-2127-422b-91ae-364da2661108)

How SecUtils Interprets This CVE

SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For philips's affected products, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.